In a report released today, Steve Manaker from Stifel Nicolaus maintained a Hold rating on National Health Investors (NHI – Research Report), with a price target of $55.00. The company’s shares closed yesterday at $54.12.
According to TipRanks, Manaker is a 5-star analyst with an average return of 14.1% and a 64.36% success rate. Manaker covers the Real Estate sector, focusing on stocks such as National Health Investors, Prologis, and Rexford Industrial Realty.
National Health Investors has an analyst consensus of Hold, with a price target consensus of $54.17, representing a 0.09% upside. In a report released yesterday, Wells Fargo also assigned a Hold rating to the stock with a $55.00 price target.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $57.06 and a one-year low of $45.56. Currently, National Health Investors has an average volume of 152.2K.
Based on the recent corporate insider activity of 8 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of NHI in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
National Health Investors (NHI) Company Description:
National Health Investors, Inc. is a real estate investment trust, which engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes lease, mortgage and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals and medical office buildings. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.
Read More on NHI:
